Prevalence of Myopic Maculopathy Among the Very Old: The Ural Very Old Study
Investigative Opthalmology & Visual Science · 21.03.2024 · 65 (3) · 29
DOI: 10.1167/iovs.65.3.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 21.03.2024. Verfasst von Mukharram M Bikbov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ufa Eye Research Institute, Ufa, Russia. Hauptthemen laut MEDLINE: Macular Degeneration, Retinal Diseases, Myopia, Degenerative. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ufa Eye Research Institute, Ufa, Russia.
- Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany.
- Privatpraxis Prof Jonas und Dr Panda-Jonas, Heidelberg, Germany.
- Institute of Molecular and Clinical Ophthalmology IOB, Basel, Switzerland.
- Singapore Eye Research Institute, Singapore, Singapore.
- Tsinghua Medicine, Tsinghua University, Beijing, China.
Zitieren
APA
Bikbov, M. M., Gilmanshin, T. R., Kazakbaeva, G. M., Panda-Jonas, S., & Jonas, J. B. (2024). Prevalence of Myopic Maculopathy Among the Very Old: The Ural Very Old Study. Investigative Opthalmology & Visual Science, 65(3), 29. https://doi.org/10.1167/iovs.65.3.29
Vancouver
Bikbov MM, Gilmanshin TR, Kazakbaeva GM, Panda-Jonas S, Jonas JB. Prevalence of Myopic Maculopathy Among the Very Old: The Ural Very Old Study. Investigative Opthalmology & Visual Science. 2024;65(3):29. doi:10.1167/iovs.65.3.29
BibTeX
@article{Bikbov2024,
author = {Bikbov, Mukharram M and Gilmanshin, Timur R and Kazakbaeva, Gyulli M and Panda-Jonas, Songhomitra and Jonas, Jost B},
title = {Prevalence of Myopic Maculopathy Among the Very Old: The Ural Very Old Study},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
volume = {65},
number = {3},
pages = {29},
doi = {10.1167/iovs.65.3.29}
}
EUVIMED